Intocell Inc (287840)

Currency in KRW
24,700.00
+200.00(+0.82%)
Closed·
287840 Scorecard
Full Analysis
Stock generally trades with high price volatility
Trading near 52-week Low
Fair Value
Day's Range
23,250.0024,800.00
52 wk Range
23,250.0052,400.00
Key Statistics
Bid/Ask
24,650.00 / 24,700.00
Prev. Close
24,500
Open
24,000
Day's Range
23,250-24,800
52 wk Range
23,250-52,400
Volume
171.45K
Average Volume (3m)
1.15M
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
287840 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Biotechnology industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Intocell Inc Company Profile

IntoCell, Inc. develops protein-drug conjugates for the treatment of cancer. It develops antibody drug conjugates (ADC), fusion albumin drug conjugates, and triple conjugates. The company also develops B7-H3 ADC, which is in preclinical Phase for the treatment of solid cancers, as well as HER3 ADC, 5T4 ADC, and PSMA ADC for solid cancers. In addition, it develops Ortho-Hydroxy Protected Aryl Sulfate (OHPAS), a novel self-immolative group that designs to incorporate various functional groups for linking targeting moieties; and OHPASM Linker-toxin Library, an optimized linker-toxin library for fast delivery of a pre-clinical candidate in novel ADC programs. The company was founded in 2015 and is based in Daejeon, South Korea.

Compare 287840 to Peers and Sector

Metrics to compare
287840
Peers
Sector
Relationship
P/E Ratio
−41.0x−12.1x−0.5x
PEG Ratio
−0.87−0.080.00
Price/Book
93.8x2.5x2.6x
Price / LTM Sales
124.4x27.6x3.2x
Upside (Analyst Target)
-0.0%41.2%
Fair Value Upside
Unlock9.9%6.2%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-254.00 / --
Revenue / Forecast
109.17M / --
EPS Revisions
Last 90 days

287840 Income Statement

People Also Watch

262,500
000660
+0.19%
456,500
196170
-0.11%
567,000
214450
+3.66%
77,900
298380
-4.18%
233,000
035420
-1.06%

FAQ

What Stock Exchange Does Intocell Trade On?

Intocell is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Intocell?

The stock symbol for Intocell is "287840."

What Is the Intocell Market Cap?

As of today, Intocell market cap is 363.77B.

What Is Intocell's Earnings Per Share (TTM)?

The Intocell EPS (TTM) is -679.25.

From a Technical Analysis Perspective, Is 287840 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Intocell Stock Split?

Intocell has split 0 times.

How Many Employees Does Intocell Have?

Intocell has 0 employees.

What is the current trading status of Intocell (287840)?

As of 29 Jul 2025, Intocell (287840) is trading at a price of 24,700.00, with a previous close of 24,500.00. The stock has fluctuated within a day range of 23,250.00 to 24,800.00, while its 52-week range spans from 23,250.00 to 52,400.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.